thrombolyt therapi streptokinas stimul breakdown background plasmin capabl extracellular matrix compon collagen vitro signific vivo condit effect streptokinas plasminogen serum concentr amino-termin propeptid type iii procollagen piiinp carboxy-termin propeptid type picp method result twenty-thre patient suspect acut myocardi infarct studi thrombolyt therapi piiinp picp radioimmunoassay kinet creatin kinase-mb releas reperfus nonreperfus composit curv creatin kinase-mb releas differ patient subgroup streptokinas infus serum concentr piiinp maximum mean increas micrograms/l minut similar increas patient thrombolyt therapi myocardi infarct basi enzym releas rel increas piiinp streptokinas treatment acut myocardi infarct patient probabl reperfus nonprob reperfus correspond chang piiinp control group day second increas serum piiinp patient group chang similar increas picp conclus streptokinas activ plasminogen breakdown type iii collagen thrombolyt therapi phenomenon risk rethrombosi affect arteri expos collagen respons thrombosi format develop hemorrhag complic thrombolyt therapi second increas piiinp level type iii collagen synthesi infarct area investig pilot studi studi effect variou thrombolyt agent interstiti collagen metabol 